Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study

Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study

Objectives: The aim was to evaluate the safety and effectiveness of thalidomide, an immunomodulatory agent, in combination with glucocorticoid, for the treatment of COVID-19 patients with life-threatening symptoms. Methods: A nonrandomized comparative case series study was performed. Six patients re...

Full description

Bibliographic Details
Main Authors: Yuping Li, Keqing Shi, Feng Qi, Zhijie Yu, Chengshui Chen, Jingye Pan, Gaojun Wu, Yanfang Chen, Ji Li, Yongping Chen, Tieli Zhou, Xiaokun Li, Jinglin Xia
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Infectious Diseases
Subjects:
Thalidomide
Glucocorticoid
COVID-19
Inflammatory cytokines
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220325467

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220325467

Similar Items